Patent Grant
12312437
This invention relates to complexes and methods for detecting analytes in a sample.
Water soluble fluorescent polymers can be used in a variety of biological applications by generating signals which can be monitored in real time and provide simple and rapid methods for the detection of biological targets and events.
Brightness of a dye is an overall contribution from the extinction coefficient (E, measure of the amount of light absorbed at a particular wavelength) and fluorescence quantum yield (Φ, measure of the light emitted in the form of radiation from its singlet excited state). Most of the reported organic violet dyes such as coumarin, BODIPY, cyanine, squaraine etc are single molecules and shows relatively low extinction coefficient in the range of 10,000-70,000 M−1 cm−1 at 405 nm. It has been shown that molecules having multiple chromophores exhibit higher E value due to the overall contribution from different chromophores. There are various reports on dendrimeric and polymeric backbone approaches where a single molecule contains multiple chromophores.
However, many of the previously reported polymeric dyes are highly hydrophobic and are used for material applications such as light emitting diodes, solar cells etc. Consequently, many polymeric dyes are not useful under aqueous conditions due to the poor solubility, brightness, and broadening of the spectra. Only a few reports deal with water soluble fluorescent polymers for biological applications which are excitable with a 405 nm and 355 nm laser. Therefore, identification of novel polymeric cores is needed in order to expand the arsenal of water soluble polymeric dyes for biological applications, including for the detection of analytes.
The present invention addresses these and other disadvantages of prior art complexes and methods for detecting analytes in a sample.
The present invention generally provides novel, water soluble fluorescent polymers and methods for detecting analytes in a sample using complexes comprising the fluorescent polymers conjugated to binding agents.
In a first embodiment, the present invention provides a water soluble fluorescent polymer having the structure of Formula I:
In some cases, the polymer has the structure of Formula II:
In some cases, the polymer has the structure of Formula III:
In some cases the polymer has the structure of Formula IV:
In some cases, the polymer has the structure of Formula V:
In some cases, the polymer is a copolymer and has the structure of Formula VI:
wherein g and a together is a mol % from 10 to 100%.
In some cases, the polymer is a copolymer and has the structure of Formula VII:
wherein, each g and a together is a mol % from 10 to 100%; and each f is independently an integer from 0 to 50 and each R5 is independently selected from the group consisting of H, C1-C12 alkyl, C2-C12 alkene, C2-C12 alkyne, C3-C12 cycloalkyl, C1-C12 haloalkyl, C1-C12 alkoxy, C2-C18 (hetero)aryloxy, C2-C18 (hetero)arylamino, and C1-C12 alkoxy.
In some cases, the polymer is a copolymer has the structure of Formula VIII:
In some cases, the polymer is a copolymer and has the structure of Formula IX:
In some embodiments, L is each independently selected from the group consisting of
In some embodiments, G1 and G2 are each independently selected from the group consisting of optionally substituted dihydrophenanthrene (DHP), optionally substituted fluorene, aryl substituted with one or more pendant chains terminated with a functional group, and a hetroaryl substituted with one or more pendant chains terminated with a functional group.
In some embodiments, Gf and G2 are each independently selected from the group consisting of
In some embodiments, the present invention provides a method for detecting an analyte in a sample comprising:
wherein;
In some embodiments, the method further comprises, applying a light source to the sample that can excite the polymer; and detecting whether light is emitted from the conjugated polymer complex.
In some embodiments, the binding agent is a protein, peptide, affinity ligand, antibody, antibody fragment, sugar, lipid, nucleic acid or an aptamer. In some embodiments, the binding agent is an antibody.
In some embodiments, the method is configured for flow cytometry. In some embodiments, the binding agent is bound to a substrate. In some embodiments, the analyte is a protein expressed on a cell surface.
In some embodiments, the method is configured as a immunoassay. In some embodiments, the method further comprises providing additional binding agents for detecting additional analytes simultaneously.
The present invention provides novel, water soluble fluorescent polymers and methods for detecting analytes in a sample using complexes comprising the fluorescent polymers conjugated to binding agents. The water soluble conjugated polymers of present invention demonstrate significantly increased brightness compared to other dyes.
The abbreviations used herein have their conventional meaning within the chemical and biological arts.
As used herein, the term “ammonium” refers to a cation having the formula NHR3+ where each R group, independently, is hydrogen or a substituted or unsubstituted alkyl, aryl, aralkyl, or alkoxy group. Preferably, each of the R groups is hydrogen.
As used herein, “oligoether” is understood to mean an oligomer containing structural repeat units having an ether functionality. As used herein, an “oligomer” is understood to mean a molecule that contains one or more identifiable structural repeat units of the same or different formula.
The term “sulfonate functional group” or “sulfonate,” as used herein, refers to both the free sulfonate anion (—S(═O)2O—) and salts thereof. Therefore, the term sulfonate encompasses sulfonate salts such as sodium, lithium, potassium and ammonium sulfonate.
The term “sulfonamido” as used herein refers to a group of formula —SO2NR— where R is hydrogen, alkyl or aryl.
The term “alkyl” as used herein refers to a straight or branched, saturated, aliphatic radical having the number of carbon atoms indicated. For example, C1-C6 alkyl includes, but is not limited to, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, hexyl, etc. Other alkyl groups include, but are not limited to heptyl, octyl, nonyl, decyl, etc. Alkyl can include any number of carbons, such as 1-2, 1-3, 1-4, 1-5, 1-6, 1-7, 1-8, 1-9, 1-10, 2-3, 2-4, 2-5, 2-6, 3-4, 3-5, 3-6, 4-5, 4-6 and 5-6. The alkyl group is typically monovalent, but can be divalent, such as when the alkyl group links two moieties together.
The term “cycloalkyl” as used herein refers to a saturated or partially unsaturated, monocyclic, fused bicyclic or bridged polycyclic ring assembly containing from 3 to 12 ring atoms, or the number of atoms indicated monocyclic rings include, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, and cyclooctyl. Bicyclic and polycyclic rings include, for example, norbornane, decahydronaphthalene and adamantane. For example, C3-8cycloalkyl includes cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclooctyl, and norbornane.
The term “haloalkyl” as used herein refers to alkyl as defined above where some or all of the hydrogen atoms are substituted with halogen atoms. Halogen (halo) preferably represents chloro or fluoro, but may also be bromo or iodo. For example, haloalkyl includes trifluoromethyl, flouromethyl, 1,2,3,4,5-pentafluoro-phenyl, etc. The term “perfluoro” defines a compound or radical which has at least two available hydrogens substituted with fluorine. For example, perfluorophenyl refers to 1,2,3,4,5-pentafluorophenyl, perfluoromethane refers to 1,1,1-trifluoromethyl, and perfluoromethoxy refers to 1,1,1-trifluoromethoxy.
As used herein, the term “halogen” refers to fluorine, chlorine, bromine and iodine.
The term “alkoxy” as used herein refers to an alkyl group, as defined above, having an oxygen atom that connects the alkyl group to the point of attachment. Alkoxy groups include, for example, methoxy, ethoxy, propoxy, iso-propoxy, butoxy, 2-butoxy, iso-butoxy, sec-butoxy, tert-butoxy, pentoxy, hexoxy, etc. The alkoxy groups can be further substituted with a variety of substituents described within. For example, the alkoxy groups can be substituted with halogens to form a “halo-alkoxy” group.
The term “alkene” as used herein refers to either a straight chain or branched hydrocarbon, having at least one double bond. Examples of alkene groups include, but are not limited to, vinyl, propenyl, isopropenyl, 1-butenyl, 2-butenyl, isobutenyl, butadienyl, 1-pentenyl, 2-pentenyl, isopentenyl, 1,3-pentadienyl, 1,4-pentadienyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 1,3-hexadienyl, 1,4-hexadienyl, 1,5-hexadienyl, 2,4-hexadienyl, or 1,3,5-hexatrienyl. The alkene group is typically monovalent, but can be divalent, such as when the alkenyl group links two moieties together.
The term “alkyne” as used herein refers to either a straight chain or branched hydrocarbon, having at least one triple bond. Examples of alkynyl groups include, but are not limited to, acetylenyl, propynyl, 1-butynyl, 2-butynyl, isobutynyl, sec-butynyl, butadiynyl, 1-pentynyl, 2-pentynyl, isopentynyl, 1,3-pentadiynyl, 1,4-pentadiynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 1,3-hexadiynyl, 1,4-hexadiynyl, 1,5-hexadiynyl, 2,4-hexadiynyl, or 1,3,5-hexatriynyl. The alkynyl group is typically monovalent, but can be divalent, such as when the alkynyl group links two moieties together.
The term “aryl” as used herein refers to a monocyclic or fused bicyclic, tricyclic or greater, aromatic ring assembly containing 6 to 16 ring carbon atoms. For example, aryl may be phenyl, benzyl or naphthyl, preferably phenyl. “Arylene” means a divalent radical derived from an aryl group. Aryl groups can be mono-, di- or tri-substituted by one, two or three radicals selected from alkyl, alkoxy, aryl, hydroxy, halogen, cyano, amino, amino-alkyl, trifluoromethyl, alkylenedioxy and oxy-C2-C3-alkylene; all of which are optionally further substituted, for instance as hereinbefore defined; or 1- or 2-naphthyl; or 1- or 2-phenanthrenyl. Alkylenedioxy is a divalent substitute attached to two adjacent carbon atoms of phenyl, e.g. methylenedioxy or ethylenedioxy. Oxy-C2-C3-alkylene is also a divalent substituent attached to two adjacent carbon atoms of phenyl, e.g. oxyethylene or oxypropylene. An example for oxy-C2-C3-alkylene-phenyl is 2,3-dihydrobenzofuran-5-yl.
Preferred as aryl is naphthyl, phenyl or phenyl mono- or disubstituted by alkoxy, phenyl, halogen, alkyl or trifluoromethyl, especially phenyl or phenyl-mono- or disubstituted by alkoxy, halogen or trifluoromethyl, and in particular phenyl.
The term “aryloxy” as used herein refers to a O-aryl group, wherein aryl is as defined above. An aryloxy group can be unsubstituted or substituted with one or two suitable substituents. The term “phenoxy” refers to an aryloxy group wherein the aryl moiety is a phenyl ring. The term “heteroaryloxy” as used herein means an —O-heteroaryl group, wherein heteroaryl is as defined below. The term “(hetero)aryloxy” is use to indicate the moiety is either an aryloxy or heteroaryloxy group.
The terms “Polyethylene glycol” or “PEG” as used herein refer to the family of biocompatible water-solubilizing linear polymers based on the ethylene glycol monomer unit.
The term “heteroaryl” as used herein refers to a monocyclic or fused bicyclic or tricyclic aromatic ring assembly containing 5 to 16 ring atoms, where from 1 to 4 of the ring atoms are a heteroatom each N, O or S. For example, heteroaryl includes pyridyl, indolyl, indazolyl, quinoxalinyl, quinolinyl, isoquinolinyl, benzothienyl, benzofuranyl, furanyl, pyrrolyl, thiazolyl, benzothiazolyl, oxazolyl, isoxazolyl, triazolyl, tetrazolyl, pyrazolyl, imidazolyl, thienyl, or any other radicals substituted, especially mono- or di-substituted, by e.g. alkyl, nitro or halogen. Pyridyl represents 2-, 3- or 4-pyridyl, advantageously 2- or 3-pyridyl. Thienyl represents 2- or 3-thienyl. Quinolinyl represents preferably 2-, 3- or 4-quinolinyl. Isoquinolinyl represents preferably 1-, 3- or 4-isoquinolinyl. Benzopyranyl, benzothiopyranyl represents preferably 3-benzopyranyl or 3-benzothiopyranyl, respectively. Thiazolyl represents preferably 2- or 4-thiazolyl, and most preferred, 4-thiazolyl. Triazolyl is preferably 1-, 2- or 5-(1,2,4-triazolyl). Tetrazolyl is preferably 5-tetrazolyl.
Preferably, heteroaryl is pyridyl, indolyl, quinolinyl, pyrrolyl, thiazolyl, isoxazolyl, triazolyl, tetrazolyl, pyrazolyl, imidazolyl, thienyl, furanyl, benzothiazolyl, benzofuranyl, isoquinolinyl, benzothienyl, oxazolyl, indazolyl, or any of the radicals substituted, especially mono- or di-substituted.
Similarly, substituents for the aryl and heteroaryl groups are varied and are selected from: -halogen, —OR′, —OC(O)R′, —NR′R″, —SR′, —R′, —CN, —NO2, —CO2R′, —CONR′R″, —C(O)R′, —OC(O)NR′R″, —NR″C(O)R′, —NR″C(O)2R′, —NR′—C(O)NR′R″′, —NH—C(NH2)═NH, —NR′C(NH2)═NH, —NH—C(NH2)═NR′, —S(O)R′, —S(O)2R′, —S(O)2NR′R″, —N3, —CH(Ph)2, perfluoro(C1-C4)alkoxy, and perfluoro(C1-C4)alkyl, in a number ranging from zero to the total number of open valences on the aromatic ring system; and where R′, R″ and R″′ are independently selected from hydrogen, (C1-C8)alkyl and heteroalkyl, unsubstituted aryl and heteroaryl, (unsubstituted aryl)-(C1-C4)alkyl, and (unsubstituted aryl)oxy-(C1-C4)alkyl.
Two of the substituents on adjacent atoms of the aryl or heteroaryl ring may optionally be replaced with a substituent of the formula -T-C(O)—(CH2)q—U—, wherein T and U are independently —NH—, —O—, —CH2— or a single bond, and q is an integer of from 0 to 2. Alternatively, two of the substituents on adjacent atoms of the aryl or heteroaryl ring may optionally be replaced with a substituent of the formula -A-(CH2)r—B—, wherein A and B are independently —CH2—, —O—, —NH—, —S—, —S(O)—, —S(O)2—, —S(O)2NR′— or a single bond, and r is an integer of from 1 to 3. One of the single bonds of the new ring so formed may optionally be replaced with a double bond. Alternatively, two of the substituents on adjacent atoms of the aryl or heteroaryl ring may optionally be replaced with a substituent of the formula —(CH2)s—X—(CH2)t—, where s and t are independently integers of from 0 to 3, and X is —O—, —NR′—, —S—, —S(O)—, —S(O)2—, or —S(O)2NR′—. The substituent R′ in —NR′— and —S(O)2NR′— is selected from hydrogen or unsubstituted (C1-C6)alkyl.
The term “(hetero)arylamino” as used herein refers an amine radical substituted with an aryl group (e.g., —NH-aryl). An arylamino may also be an aryl radical substituted with an amine group (e.g., -aryl-NH2). Arylaminos may be substituted or unsubstituted.
The term “amine” as used herein refers to an alkyl groups as defined within, having one or more amino groups. The amino groups can be primary, secondary or tertiary. The alkyl amine can be further substituted with a hydroxy group. Amines useful in the present invention include, but are not limited to, ethyl amine, propyl amine, isopropyl amine, ethylene diamine and ethanolamine. The amino group can link the alkyl amine to the point of attachment with the rest of the compound, be at the omega position of the alkyl group, or link together at least two carbon atoms of the alkyl group. One of skill in the art will appreciate that other alkyl amines are useful in the present invention.
The term “carbamate” as used herein refers to the functional group having the structure —NR″CO2R′, where R′ and R″ are independently selected from hydrogen, (C1-C5)alkyl and heteroalkyl, unsubstituted aryl and heteroaryl, (unsubstituted aryl)-(C1-C4)alkyl, and (unsubstituted aryl)oxy-(C1-C4)alkyl. Examples of carbamates include t-Boc, Fmoc, benzyloxy-carbonyl, alloc, methyl carbamate, ethyl carbamate, 9-(2-sulfb)fluorenylmethyl carbamate, 9-(2,7-dibromo)fluorenylmethyl carbamate, Tbfmoc, Climoc, Bimoc, DBD-Tmoc, Bsmoc, Troc, Teoc, 2-phenylethyl carbamate, Adpoc, 2-chloroethyl carbamate, 1,1-dimethyl-2-haloethyl carbamate, DB-t-BOC, TCBOC, Bpoc, t-Bumeoc, Pyoc, Bnpeoc, V-(2-pivaloylamino)-1,1-dimethylethyl carbamate, NpSSPeoc.
The term “carboxylate” as used herein refers to the conjugate base of a carboxylic acid, which generally can be represented by the formula RCOO. For example, the term “magnesium carboxylate” refers to the magnesium salt of the carboxylic acid.
The term “activated ester” as used herein refers to carboxyl-activating groups employed in peptide chemistry to promote facile condensation of a carboxyl group with a free amino group of an amino acid derivative. Descriptions of these carboxyl-activating groups are found in general textbooks of peptide chemistry; for example K. D. Kopple, “Peptides and Amino Acids”, W. A. Benjamin, Inc., New York, 1966, pp. 50-51 and E. Schroder and K. Lubke, “The Peptides”; Vol. 1, Academic Press, New York, 1965, pp. 77-128.
The terms “hydrazine” and “hydrazide” refer to compounds that contain singly bonded nitrogens, one of which is a primary amine functional group.
The term “aldehyde” as used herein refers to a chemical compound that has an —CHO group.
The term “thiol” as used herein refers to a compound that contains the functional group composed of a sulfur-hydrogen bond. The general chemical structure of the thiol functional group is R—SH, where R represents an alkyl, alkene, aryl, or other carbon-containing group of atoms.
The term “silyl” as used herein refers to Si(Rz)3 wherein each Rz independently is alkyl aryl or other carbon-containing group of atoms.
The term “diazonium salt” as used herein refers to a group of organic compounds with a structure of R—N2+X−, wherein R can be any organic residue (e.g., alkyl or aryl) and X is an inorganic or organic anion (e.g., halogen).
The term “triflate” also referred to as trifluoromethanesulfonate, is a group with the formula CF3SO3.
The term “boronic acid” as used herein refers to a structure —B(OH)2. It is recognized by those skilled in the art that a boronic acid may be present as a boronate ester at various stages in the synthesis of the quenchers. Boronic acid is meant to include such esters. The term “boronic ester” or “boronate ester” as used herein refers to a chemical compound containing a —B(Z1)(Z2) moiety, wherein Z1 and Z2 together form a moiety where the atom attached to boron in each case is an oxygen atom. In some embodiments, the boronic ester moiety is a 5-membered ring. In some other embodiments, the boronic ester moiety is a 6-membered ring. In some other embodiments, the boronic ester moiety is a mixture of a 5-membered ring and a 6-membered ring.
Polymers
The compounds of the present invention comprise water soluble fluorescent polymers having the structure of Formulas I-XIII. In some embodiments, polymers of the present invention utilize dihydrophenanthrene (DHP), fluorene, and combinations of DHP and fluorene monomers as shown in Formula I:
The polymers complexes of the present invention can contain units capable of altering the polymer band gap and are evenly or randomly distributed along the polymer main chain. These unites are represented in Formula I as M. The polymers complexes of the present invention can also contain linkers represented in Formula I as L. Each optional linker L is an aryl or hetroaryl group evenly or randomly distributed along the polymer main chain and are substituted with one or more pendant chains terminated with a functional group selected from the group consisting of amine, carbamate, carboxylic acid, carboxylate, maleimide, activated ester, N-hydroxysuccinimidyl, hydrazine, hydrazide, hydrazone, azide, alkyne, aldehyde, thiol, and protected groups thereof for conjugation to a substrate or binding agent.
The polymers complexes of the present invention also contain capping units represented in Formula I as each G1 and G2, which are each independently selected from the group consisting of hydrogen, halogen, alkyne, optionally substituted aryl, optionally substituted heteroaryl, halogen substituted aryl, silyl, diazonium salt, triflate, acetyloxy, azide, sulfonate, phosphate, boronic acid substituted aryl, boronic ester substituted aryl, boronic ester, boronic acid, optionally substituted dihydrophenanthrene (DHP), optionally substituted fluorene, aryl or hetroaryl substituted with one or more pendant chains terminated with a functional group selected from amine, carbamate, carboxylic acid, carboxylate, maleimide, activated ester, N-hydroxysuccinimidyl, hydrazine, hydrazide, hydrazone, azide, alkyne, aldehyde, thiol, and protected groups thereof for conjugation to a substrate or binding agent.
In some cases, the polymer has the structure of Formula II:
In some cases the polymer has the structure of Formula IV:
In some cases, the polymer has the structure of Formula V:
In some cases, the polymer is a copolymer and has the structure of Formula VI:
In some cases, the polymer is a copolymer and has the structure of Formula VII:
In some embodiments, the polymer has acceptor dyes attached to the backbone that will allow to excite the polymer backbone and see monitor the emission of the acceptor dyes attached to the back bone through energy transfer. Acceptor dyes useful in the invention include FITC, CY3B, Cy55, Alexa 488, Texas red, Cy5, Cy7, Alexa 750, and 800CW. For example, polymers with acceptor dyes of the present invention include:
Monomers
Monomers of the present invention include dihydrophenanthrene (DHP) and fluorene based monomers. For example, monomers of the present invention include:
Where both terminal ends of the monomers are independently or both a halogen atom, boronic ester or boronic acid, silyl, diazonium salt, triflate, acetyloxy, sulfonate, or phosphate which can undergo Pd or Nickel salt catalyzed polymerization reactions. R1 is independently a side group capable of imparting solubility in water/buffer and each R1 is independently selected from the group consisting of ammonium alkyl salt, ammonium alkyloxy salt, ammonium oligoether salt, sulfonate alkyl salt, sulfonate alkoxy salt, sulfonate oligoether salt, sulfonamido oligoether, and
each R2 is independently selected from the group consisting of H, alkyl, alkene, alkyne, cycloalkyl, haloalkyl, alkoxy, (hetero)aryloxy, aryl, (hetero)arylamino, PEG, ammonium alkyl salt, ammonium alkyloxy salt, ammonium oligoether salt, sulfonate alkyl salt, sulfonate alkoxy salt, sulfonate oligoether salt, sulfonamido oligoether, and
each R3 is independently selected from the group consisting of H, alkyl, alkene, alkyne, cycloalkyl, haloalkyl, alkoxy, (hetero)aryloxy, aryl, (hetero)arylamino, and PEG; each Z is independently selected from the group consisting of C, O, and N; each Q is independently selected from the group consisting of a bond, NH, NR4 and CH2; and each R5 is independently selected from the group consisting of H, C1-C12 alkyl, C2-C12 alkene, C2-C12 alkyne, C3-C12 cycloalkyl, C1-C12 haloalkyl, C1-C12 alkoxy, C2-C18 (hetero)aryloxy, C2-C18 (hetero)arylamino, and C1-C12 alkoxy.
In some embodiments, monomers of the present invention also include bridged monomers. For example, bridged monomers of the present invention include:
Synthesis
DHP monomers of the present invention can be made as shown below.
For example, 2,7-dibromo-trans-9,10-dihydrophenanthrene-9,10-diol (DHP-OH) can be prepared as follows. In a conical flask (2000 L), add about 26 g of NaBH4 into a stirring water-ethanol mixture (120 mL+780 mL). To this solution, add about 24 g of 2,7-dibromophenanthrene,9,10-dione portion-wise but quickly (in 5 min). The reaction mix allowed stirring for a day. The color of the solution changes from orange red to pale yellow to white by the end of the reaction. Stop the reaction and neutralize the reaction mixture with dil HCl acid. After the neutralization, filter the white precipitate and wash with excess water. Thus obtained white precipitate was washed with very cold (<−15° C.) ethanol (100 mL) and Methanol (100 mL).
DHP-OSO3H can be prepared as follows. In a 2 neck round bottom flask, DHP-OH (3.6 g) and 18C6 (500 mg) were dissolved in 120 mL of THF. The solution was purged with nitrogen (20 min) and NaH (2 g) was added while nitrogen purging continues. The color of the solution changes from colorless to pale pink, dark pink, brown and dark green in 10-15 min. In another RB, 12 g of 1,3 propane sultone was dissolved in 20 mL of THE and nitrogen purged. This sultone solution was added to DHP-OH solution by addition funnel over a period of 20-30 minutes. The reaction was stirred at RT for 4-5 hrs. The solvents were evaporated, and dissolved the precipitate in water. Acetone was added to obtain white precipitate of DPS in the form of disodium salt. Filter the precipitate and redissolve in water (minimal amount) neutralize with HCl and precipitate again in acetone. Repeated precipitation (2-3 times) followed by centrifugation gives DPS as white solid.
DHP-OSO2Cl can be prepared as follows. 5 g of DHP-OSO3H was taken in a round bottom flask and mixed with 25 mL of DMF. To this about 10 mL of SOCl2 was added dropwise and the mixture allowed to stir for overnight. Next morning, reaction mixture was poured into 200 mL water and precipitate was filtered and dried.
DHP-sulfonamide PEG can be prepared as follows. DHP-OSO2Cl was mixed with 2.2 equivalent of PEG amine in dichloromethane/TEA mixture. After 3 h sonication reaction the crude product was extracted in dichloromethane followed by column chromatography (silica gel, MeOH—CHCl3).
Diboronic ester of DHP-sulfonamide PEG can be prepared as follows. The dibromo compound was mixed with DMSO under nitrogen and to this 3 equivalent of bispinacolatodiboron was added. The reagents were reacted with 12 equivalent of potassium acetate and 4 equivalent of Pd(dppf)Cl2 catalyst for 5 hours at 80 deg. Reaction mixture cooled down and extracted with CHCl3/water. The organic layer was concentrated and purified by column chromatography (silica gel, MeOH—CHCl3).
Similarly, Fluorene monomers of the present invention can be made as described below. For example, FL-OSO3H can be prepared as follows. In a 2 neck round bottom flask, 5 g of Fluorene was mixed with in 70 of DMSO. The solution was purged with nitrogen (20 min) and 50% NaOH (12 eq) was added while nitrogen purging continues. The color of the solution changes from colorless to dark brown. Propane sultone (3 eq) was weighed and dissolved in DMSO. This was added to the fluorene reaction mixture dropwise over a period of 5 minutes. The reaction was stirred at RT for 4-5 hrs. The solvents were evaporated, and dissolved the precipitate in water. Acetone was added to obtain white precipitate of DPS in the form of disodium salt. Filter the precipitate and redissolve in water (minimal amount) neutralize with HCl and precipitate again in acetone. Repeated precipitation (2-3 times) followed by centrifugation gives FL-OSO3H as white solid.
FL-OSO2C1 can be prepared as follows. 5 g of FL-OSO3H was taken in a round bottom flask and mixed with 25 mL of DMF. To this about 10 mL of SOCl2 was added dropwise and the mixture allowed to stir for overnight. Next morning, reaction mixture was poured into 200 mL water and precipitate was filtered and dried.
FL-sulfonamide PEG can be prepared as follows. FL-OSO2Cl was mixed with 2.2 equivalent of PEG amine in dichloromethane/TEA mixture. After 3 h sonication reaction the crude product was extracted in dichloromethane followed by column chromatography (silica gel, MeOH—CHCl3).
Diboronic ester of FL-sulfonamide PEG can be prepared as follows. The dibromo compound was mixed with DMSO under nitrogen and to this 3 equivalent of bispinacolatodiboron was added. The reagents were reacted with 12 equivalent of potassium acetate and 4 equivalent of Pd(dppf)Cl2 catalyst for 5 hours at 80 deg. Reaction mixture cooled down and extracted with CHCl3/water. The organic layer was concentrated and purified by column chromatography (silica gel, MeOH—CHCl3).
Polymerization
The compounds described in the above embodiments may be made using procedures known in the art. In some embodiments, fluorescent polymers can be made from dihydrophenanthrene (DHP) monomers combined with electron rich linker units. In some embodiments, bright polymeric dyes can be made from fluorene monomers combined with electron rich linker units. In some embodiments, bright polymeric dyes can be made from a combination of DHP and fluorene monomers combined with electron rich linker units.
Generally, polymerization monomer units described above can be accomplished using polymerization techniques known to those of skill in the art or using methods known in the art in combination with methods described herein. For example, Synthesis of diboronic ester derivatives from a dihalide monomer can be accomplished via Suzuki coupling with bis(pinacolato) diboron:
Similarly, polymerization can also be achieved via Suzuki coupling:
Where J1 and J2 are independently H, Br, B(OH)2, or a boronic ester.
For example, polymerization can proceed as follows. In a round bottom flask both the bromo and boronic monomers were taken in (DMF-water) mixture and purged with nitrogen for 10 minutes. Under nitrogen about 20 equivalent of CsF and 10% of Pd(OAc)2 were mixed and heated at 800 Celcius. Polymerization was monitored using UV-Vis spectroscopy and SEC chromatography. Later to the reaction mixture, a capping agent (selected from G1) containing appropriate functional group was added and 3 hours later the second capping agent (selected from G2) added. After the reaction the crude reaction mixture was evaporated off and passed through a gel filtration column to remove small organic molecules and low MW oligomers.
Capping Units
Linkers and capping units can be conjugated to a polymer backbone of this invention via similar mechanisms as described previously. For example, bromo- and boronic esters of capping units can be used to append one or both ends of a polymer. Utilizing both bromo- and boronic esters of capping units will append both ends of polymer. Utilizing only one form, either a bromo- or boronic ester of a capping unit, will append only those ends terminated with its respective complement and for symmetric polymerizations can be used to statistically modify only one end of a polymer. For asymmetric polymers this approach is used to chemically ensure the polymers are only modified at a single chain terminus. Capping units can also be appended asymmetrically by first reacting a bromo-capping unit with a polymer with Y ends and subsequently reacting the polymer with a boronic ester capping unit.
For example, capping agents of the present invention can be made as shown below.
Binding Agents
A “binding agent” of the invention can be any molecule or complex of molecules capable of specifically binding to target analyte. A binding agent of the invention includes for example, proteins, small organic molecules, carbohydrates (including polysaccharides), oligonucleotides, polynucleotides, lipids, affinity ligand, antibody, antibody fragment, an aptamer and the like. In some embodiments, the binding agent is an antibody or fragment thereof. Specific binding in the context of the present invention refers to a binding reaction which is determinative of the presence of a target analyte in the presence of a heterogeneous population. Thus, under designated assay conditions, the specified binding agents bind preferentially to a particular protein or isoform of the particular protein and do not bind in a significant amount to other proteins or other isoforms present in the sample.
When the binding agents are antibodies, they may be monoclonal or polyclonal antibodies. The term antibody as used herein refers to immunoglobulin molecules and immunologically active portions of immunoglobulin (Ig) molecules. Such antibodies include, but are not limited to, polyclonal, monoclonal, mono-specific polyclonal antibodies, antibody mimics, chimeric, single chain, Fab, Fab′ and F(ab′)2 fragments, Fv, and an Fab expression library.
Complexes
In general, fluorescent polymers of the present invention can be conjugated to binding agents using techniques known to those of skill in the art or using methods known in the art in combination with methods described herein.
For example, preparation of polymer NHS ester can proceed as follows. Take 5 mg of the polymer in a clean vial and dissolve in 1 mL dry CH3CN. To this add 15 mg TSTU and stir for 2 more minutes. To this add 100 uL DIPEA and continue stirring for overnight with the cap sealed with parafilm. Later evaporate off the organic solvents in the reaction mixture Dissolve the crude NHS in about 750 uL of 1×BBS buffer (pH 8.8) by a quick vortex and transfer it to the Zeba column 40K MWCO. Spin down the sample at 2200 RPM for 2 min and use this polymer NHS immediately.
Conjugation of polymer NHS with CD4 can proceed as follows. Take the polymer NHS in 1×BBS (˜800 uL) which was spun down, add to 0.6 mg of CD4 and mix with 100 uL of 0.5M Borate buffer (pH 9.0). Vortex quickly for 30 seconds and allow to mix for 3-4 hours in the coulter mix.
Purification of conjugate through Histrap HP column can proceed as follows. Approach 1: After the crude reaction purify the conjugate using a Histrap HP column. Load the sample using 1×PBS buffer and collect the unbound fraction. This can be done using 20CV of buffer. Later change the buffer to wash the bound fraction which has both conjugate and free antibody. This can be done using 1×PBS with 0.25M imidazole running for 10 CV.
Approach 2: Hitrap SP Sepharose FF column. Equilibrate the column and load the sample using 20 mM Citrate buffer pH 3.5 and collect the unbound fraction. This can be done using 20CV of buffer. Later change the buffer to elute the bound fraction which has both conjugate and free antibody. This can be done using 20 mM Tris buffer pH 8.5 running for 20CV.
Approach 3: Load the crude conjugate in a Tangential flow filtration system equipped with a 300K MWCO membrane. The conjugate is washed using 1×PBS until the filtrate show no absorption at 405 nm. Later the compound is concentrated.
Purification of conjugate through SEC column can proceed as follows. Load the crude conjugate containing free antibody to the Size Exclusion Column, using 1×PBS. Pool the tubes after checking the absorption spectra and concentrate in a Amicon Ultra-15 having a 30 KDa MWCO centrifugal concentrator.
Overview
The present invention provides a method for detecting an analyte in a sample comprising: providing a sample that is suspected of containing an analyte; providing a conjugated polymer complex, which comprises a binding agent conjugated to a water soluble conjugated polymer. The binding agent is capable of interacting with the analyte. A light source is applied to the sample that can excite the polymer and light emitted from the conjugated polymer complex is detected. In the typical assay, fluorescent polymers of the invention are excitable with a light having wavelength between about 395 nm and about 415 nm. The emitted light is typically between about 415 nm and about 475 nm. Alternatively, excitation light can have a wavelength between about 340 nm and about 370 nm and the emitted light is between about 390 nm and about 420 nm.
Sample
The sample in the methods of the present invention can be, for example, blood, bone marrow, spleen cells, lymph cells, bone marrow aspirates (or any cells obtained from bone marrow), urine (lavage), serum, saliva, cerebral spinal fluid, urine, amniotic fluid, interstitial fluid, feces, mucus, or tissue (e.g., tumor samples, disaggregated tissue, disaggregated solid tumor). In certain embodiments, the sample is a blood sample. In some embodiments, the blood sample is whole blood. The whole blood can be obtained from the subject using standard clinical procedures. In some embodiments, the sample is a subset of one or more cells of whole blood (e.g., erythrocyte, leukocyte, lymphocyte (e.g., T cells, B cells or NK cells), phagocyte, monocyte, macrophage, granulocyte, basophil, neutrophil, eosinophil, platelet, or any cell with one or more detectable markers). In some embodiments, the sample can be from a cell culture.
The subject can be a human (e.g., a patient suffering from a disease), a commercially significant mammal, including, for example, a monkey, cow, or horse. Samples can also be obtained from household pets, including, for example, a dog or cat. In some embodiments, the subject is a laboratory animal used as an animal model of disease or for drug screening, for example, a mouse, a rat, a rabbit, or guinea pig.
Analytes
An “analyte” as used herein, refers to a substance, e.g., molecule, whose abundance/concentration is determined by some analytical procedure. For example, in the present invention, an analyte can be a protein, peptide, nucleic acid, lipid, carbohydrate or small molecule.
The target analyte may be, for example, nucleic acids (DNA, RNA, mRNA, tRNA, or rRNA), peptides, polypeptides, proteins, lipids, ions, monosaccharides, oligosaccharides, polysaccharides, lipoproteins, glycoproteins, glycolipids, or fragments thereof. In some embodiments, the target analyte is a protein and can be, for example, a structural microfilament, microtubule, and intermediate filament proteins, organelle-specific markers, proteasomes, transmembrane proteins, surface receptors, nuclear pore proteins, protein/peptide translocases, protein folding chaperones, signaling scaffolds, ion channels and the like. The protein can be an activatable protein or a protein differentially expressed or activated in diseased or aberrant cells, including but not limited to transcription factors, DNA and/or RNA-binding and modifying proteins, nuclear import and export receptors, regulators of apoptosis or survival and the like.
Assays
Assay systems utilizing a binding agent and a fluorescent label to quantify bound molecules are well known. Examples of such systems include flow cytometers, scanning cytometers, imaging cytometers, fluorescence microscopes, and confocal fluorescent microscopes.
In some embodiments, flow cytometry is used to detect fluorescence. A number of devices suitable for this use are available and known to those skilled in the art. Examples include BCI Navios, Gallios, Aquios, and CytoFLEX flow cytometers.
In other embodiments, the assay is an immunoassay. Examples of immunoassays useful in the invention include, but are not limited to, fluoroluminescence assay (FLA), and the like. The assays can also be carried out on protein arrays.
When the binding agents are antibodies, antibody or multiple antibody sandwich assays can also be used. A sandwich assay refers to the use of successive recognition events to build up layers of various binding agents and reporting elements to signal the presence of a particular analyte. Examples of sandwich assays are disclosed in U.S. Pat. No. 4,486,530 and in the references noted therein.
Method 1: In a round bottom flask both the dibromo DHP and diboronic DHP monomers (1:1) were taken in (DMF-water) mixture and purged with nitrogen for 10 minutes. Under nitrogen about 20 equivalent of CsF and 10% of Pd(OAc)2 were mixed and heated at 80 deg. Celsius. Polymerization was monitored using UV-Vis spectroscopy and SEC chromatography. Later to the reaction mixture, a capping agent (selected from G1) containing appropriate functional group was added and 3 hours later the second capping agent (selected from G2) added. After the reaction the crude reaction mixture was evaporated off and passed through a gel filtration column to remove small organic molecules and low MW oligomers. Later the crude polymer passed through a Tangential flow filtration system equipped with a 100 K MWCO membrane. It is washed using 20% ethanol until the absorption of the filtrate diminishes.
Method 2: Alternatively, the polymerization can be done by self-polymerizing a bromo-boronic ester of DHP molecule. In a round bottom flask DHP bromoboronic ester was taken in (DMF-water) mixture and purged with nitrogen for 10 minutes. Under nitrogen about 10 equivalent of CsF and 5% of Pd(OAc)2 were mixed and heated at 80 deg. Celsius. Polymerization was monitored using UV-Vis spectroscopy and SEC chromatography. Later to the reaction mixture, a capping agent (selected from G1) containing appropriate functional group was added and 3 hours later the second capping agent (selected from G2) added. After the reaction the crude reaction mixture was evaporated off and passed through a gel filtration column to remove small organic molecules and low MW oligomers. Later the crude polymer passed through a Tangential flow filtration system equipped with a 100K MWCO membrane. It is washed using 20% ethanol until the absorption of the filtrate diminishes.
Method 3: In a round bottom flask both the dibromo dihydrophenanthrene and diboronic dihydrophanenthrene monomers (1:1) were taken and dissolved in THF-water (4:1) mixture containing 10 equivalent of K2CO3 and 3% Pd(PPh3)4. The reaction mixture was put on a Schlenk line and was degassed with three freeze-pump-thaw cycles and then heated to 80 deg. C. under nitrogen with vigorous stirring for 18 hours. Later to the reaction mixture, a capping agent (selected from G1) containing appropriate functional group was added via a cannula under excess nitrogen pressure and 3 hours later the second capping agent (selected from G2) added. After the reaction the crude reaction mixture was evaporated off and passed through a gel filtration column to remove small organic molecules and low MW oligomers. Later the crude polymer passed through a Tangential flow filtration system equipped with a 100K MWCO membrane. It is washed using 20% ethanol until the absorption of the filtrate diminishes.
Method 4: Alternatively the polymerization can be done by self-polymerizing a bromo-boronic ester of dihydrophenanthrene molecule. In a round bottom flask dihydrophenanthrene bromoboronic ester was taken and dissolved in THE-water (4:1) mixture containing 10 equivalent of K2CO3 and 3% Pd(PPh3)4. The reaction mixture was put on a Schlenk line and was degassed with three freeze-pump-thaw cycles and then heated to 80 deg. C. under nitrogen with vigorous stirring for 18 hours. Later to the reaction mixture, a capping agent (selected from G1) containing appropriate functional group was added via a cannula under excess nitrogen pressure and 3 hours later the second capping agent (selected from G2) added. After the reaction the crude reaction mixture was evaporated off and passed through a gel filtration column to remove small organic molecules and low MW oligomers. Later the crude polymer passed through a Tangential flow filtration system equipped with a 100K MWCO membrane. It is washed using 20% ethanol until the absorption of the filtrate diminishes.
Method 1: In a round bottom flask both the dibromo DHP and diboronic fluorene monomers (1:1) were taken in (DMF-water) mixture and purged with nitrogen for 10 minutes. Under nitrogen about 20 equivalent of CsF and 10% of Pd(OAc)2 were mixed and heated at 80 deg. Celsius. Polymerization was monitored using UV-Vis spectroscopy and SEC chromatography. Later to the reaction mixture, a capping agent (selected from G1) containing appropriate functional group was added and 3 hours later the second capping agent (selected from G2) added. After the reaction the crude reaction mixture was evaporated off and passed through a gel filtration column to remove small organic molecules and low MW oligomers. Later the crude polymer passed through a Tangential flow filtration system equipped with a 100K MWCO membrane. It is washed using 20% ethanol until the absorption of the filtrate diminishes.
Method 2: In a round bottom flask both the dibromo fluorene and diboronic DHP monomers (1:1) were taken in (DMF-water) mixture and purged with nitrogen for 10 minutes. Under nitrogen about 20 equivalent of CsF and 10% of Pd(OAc)2 were mixed and heated at 80 deg. celcius. Polymerization was monitored using UV-Vis spectroscopy and SEC chromatography. Later to the reaction mixture, a capping agent (selected from G1) containing appropriate functional group was added and 3 hours later the second capping agent (selected from G2) added. After the reaction the crude reaction mixture was evaporated off and passed through a gel filtration column to remove small organic molecules and low MW oligomers. Later the crude polymer passed through a Tangential flow filtration system equipped with a 100K MWCO membrane. It is washed using 20% ethanol until the absorption of the filtrate diminishes.
Method 3: In a round bottom flask both the dibromo dihydrophenanthrene and diboronic fluorene monomers (1:1) were taken and dissolved in THF-water (4:1) mixture containing 10 equivalent of K2CO3 and 3% Pd(PPh3)4. The reaction mixture was put on a Schlenk line and was degassed with three freeze-pump-thaw cycles and then heated to 80 deg C. under nitrogen with vigorous stirring for 18 hours. Later to the reaction mixture, a capping agent (selected from G1) containing appropriate functional group was added via a cannula under excess nitrogen pressure and 3 hours later the second capping agent (selected from G2) added. After the reaction the crude reaction mixture was evaporated off and passed through a gel filtration column to remove small organic molecules and low MW oligomers. Later the crude polymer passed through a Tangential flow filtration system equipped with a 100K MWCO membrane. It is washed using 20% ethanol until the absorption of the filtrate diminishes.
Method 4: In a round bottom flask dibromo fluorene and diboronic dihydrophenanthrene monomers (1:1) were taken and dissolved in THE-water (4:1) mixture containing 10 equivalent of K2CO3 and 3% Pd(PPh3)4. The reaction mixture was put on a Schlenk line and was degassed with three freeze-pump-thaw cycles and then heated to 80 deg C. under nitrogen with vigorous stirring for 18 hours. Later to the reaction mixture, a capping agent (selected from G1) containing appropriate functional group was added via a cannula under excess nitrogen pressure and 3 hours later the second capping agent (selected from G2) added. After the reaction the crude reaction mixture was evaporated off and passed through a gel filtration column to remove small organic molecules and low MW oligomers. Later the crude polymer passed through a Tangential flow filtration system equipped with a 100K MWCO membrane. It is washed using 20% ethanol until the absorption of the filtrate diminishes.
Comparison of fluorescence emission spectra of fluorene (Fl—Fl), dihydrophenanthrene (DHP-DHP) and fluorene-DHP (DHP-Fl) polymers were undertaken. DHP containing polymers show a marked difference in their fluorescence maxima which is at 426-428 nm, whereas the fluorene based polymers show a maxima of 421 nm (
The absorption spectra of both fluorene (Fl—Fl) polymer and dihydrophenanthrene (DHP-DHP) polymer were measured. The graph shows absorption of the DHP-DHP polymer (black curve) at 390 and 410 nm, whereas the Fl—Fl(grey curve) polymer shows the maxima around 400 nm. Samples were measured under different concentration (
The flow cytometric analysis of lysed whole blood stained with the new polymers-labeled anti-human CD4 and Pacific Blue-labeled CD4 was undertaken. The positive signal intensity of polymer dyes were nearly 5 times higher than Pacific Blue (
Polymers of the present invention were found to possess certain physical and chemical characteristics of absorption, fluorescence, brightness, molecular weight, polydispersity, dye to protein ratio when conjugated to an antibody etc. The preferred ranges of these parameters are shown in the table of
The excitation and emission spectra of tandem polymers was measured. Excitation was carried out at the polymer maxima (405 nm) and the emissions observed from the various acceptor dyes attached to the backbone (
It is understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and scope of the appended claims. All publications, patents, and patent applications cited herein are hereby incorporated by reference in their entirety for all purposes.
This application is a continuation of U.S. patent application Ser. No. 17/700,219, filed Mar. 21, 2022, issued as U.S. Pat. No. U.S. Pat. No. 11,834,551 on Dec. 5, 2023, which is a continuation of U.S. patent application Ser. No. 17/395,248, filed Aug. 5, 2021, abandoned, which application is a division of U.S. patent application Ser. No. 16/092,180, filed Oct. 8, 2018, issued as U.S. Pat. No. 11,208,527 on Dec. 28, 2021, which application is a U.S. National Stage Filing under 35 U.S.C. § 371 from International Application No. PCT/US2017/027611, filed on Apr. 14, 2017, and published as WO 2017/180998 on Oct. 19, 2017, which application claims priority to U.S. Provisional Application No. 62/323,444, filed on Apr. 15, 2016, the contents of each of which is incorporated by reference herewith in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3061435 | Tomanek et al. | Oct 1962 | A |
| 4179337 | Davis et al. | Dec 1979 | A |
| 4486530 | David et al. | Dec 1984 | A |
| 4703004 | Hopp et al. | Oct 1987 | A |
| 4797414 | Rimbault | Jan 1989 | A |
| 4876029 | Güsten et al. | Oct 1989 | A |
| 5075046 | Stoll | Dec 1991 | A |
| 5089261 | Nitecki et al. | Feb 1992 | A |
| 5100992 | Cohn et al. | Mar 1992 | A |
| 5134192 | Feijen et al. | Jul 1992 | A |
| 5166309 | Maj et al. | Nov 1992 | A |
| 5171264 | Merrill | Dec 1992 | A |
| 5187288 | Kang et al. | Feb 1993 | A |
| 5213891 | Maj et al. | May 1993 | A |
| 5219564 | Zalipsky et al. | Jun 1993 | A |
| 5225584 | Brooks et al. | Jul 1993 | A |
| 5275838 | Merrill | Jan 1994 | A |
| 5281698 | Nitecki | Jan 1994 | A |
| 5298643 | Greenwald | Mar 1994 | A |
| 5312808 | Shorr et al. | May 1994 | A |
| 5321095 | Greenwald | Jun 1994 | A |
| 5324844 | Zalipsky | Jun 1994 | A |
| 5349001 | Greenwald et al. | Sep 1994 | A |
| 5352756 | Meldal | Oct 1994 | A |
| 5405877 | Greenwald et al. | Apr 1995 | A |
| 5446090 | Harris | Aug 1995 | A |
| 5453505 | Lee et al. | Sep 1995 | A |
| 5455027 | Zalipsky et al. | Oct 1995 | A |
| 5470829 | Prisell et al. | Nov 1995 | A |
| 5478805 | Shorr et al. | Dec 1995 | A |
| 5567422 | Greenwald | Oct 1996 | A |
| 5573909 | Singer et al. | Nov 1996 | A |
| 5576424 | Mao et al. | Nov 1996 | A |
| 5582977 | Yue et al. | Dec 1996 | A |
| 5605976 | Martinez et al. | Feb 1997 | A |
| 5612460 | Zalipsky | Mar 1997 | A |
| 5614549 | Greenwald et al. | Mar 1997 | A |
| 5618528 | Cooper et al. | Apr 1997 | A |
| 5637749 | Greenwald | Jun 1997 | A |
| 5643575 | Martinez et al. | Jul 1997 | A |
| 5650388 | Shorr et al. | Jul 1997 | A |
| 5656449 | Yue | Aug 1997 | A |
| 5658751 | Yue et al. | Aug 1997 | A |
| 5672662 | Harris et al. | Sep 1997 | A |
| 5681567 | Martinez et al. | Oct 1997 | A |
| 5686110 | Greenwald et al. | Nov 1997 | A |
| 5696157 | Wang et al. | Dec 1997 | A |
| 5723218 | Haugland et al. | Mar 1998 | A |
| 5728480 | Stern et al. | Mar 1998 | A |
| 5730990 | Greenwald et al. | Mar 1998 | A |
| 5739208 | Harris | Apr 1998 | A |
| 5756593 | Martinez et al. | May 1998 | A |
| 5798276 | Haugland et al. | Aug 1998 | A |
| 5808096 | Zalipsky | Sep 1998 | A |
| 5824778 | Ishikawa et al. | Oct 1998 | A |
| 5824784 | Kinstler et al. | Oct 1998 | A |
| 5840900 | Greenwald et al. | Nov 1998 | A |
| 5846737 | Kang | Dec 1998 | A |
| 5863753 | Haugland et al. | Jan 1999 | A |
| 5874500 | Rhee et al. | Feb 1999 | A |
| 5880131 | Greenwald et al. | Mar 1999 | A |
| 5900461 | Harris | May 1999 | A |
| 5902588 | Greenwald et al. | May 1999 | A |
| 5919442 | Mn et al. | Jul 1999 | A |
| 5919455 | Greenwald et al. | Jul 1999 | A |
| 5932462 | Harris et al. | Aug 1999 | A |
| 5965119 | Greenwald et al. | Oct 1999 | A |
| 5965566 | Greenwald et al. | Oct 1999 | A |
| 5985263 | Lee et al. | Nov 1999 | A |
| 5990237 | Bentley et al. | Nov 1999 | A |
| 5990479 | Weiss et al. | Nov 1999 | A |
| 6004536 | Leung et al. | Dec 1999 | A |
| 6005113 | Wu et al. | Dec 1999 | A |
| 6011042 | Greenwald et al. | Jan 2000 | A |
| 6013283 | Greenwald et al. | Jan 2000 | A |
| 6077939 | Wei et al. | Jun 2000 | A |
| 6086737 | Patonay et al. | Jul 2000 | A |
| 6113906 | Greenwald et al. | Sep 2000 | A |
| 6127355 | Greenwald et al. | Oct 2000 | A |
| 6130101 | Mao et al. | Oct 2000 | A |
| 6162931 | Gee et al. | Dec 2000 | A |
| 6177087 | Greenwald et al. | Jan 2001 | B1 |
| 6180095 | Greenwald et al. | Jan 2001 | B1 |
| 6194580 | Greenwald et al. | Feb 2001 | B1 |
| 6214966 | Harris | Apr 2001 | B1 |
| 6316267 | Bhalgat et al. | Nov 2001 | B1 |
| 6399392 | Haugland et al. | Jun 2002 | B1 |
| 6562632 | Szalecki et al. | May 2003 | B1 |
| 6562982 | Hu et al. | May 2003 | B1 |
| 6579718 | Yue et al. | Jun 2003 | B1 |
| 6670054 | Hu et al. | Dec 2003 | B1 |
| 6716979 | Diwu et al. | Apr 2004 | B2 |
| 6972326 | Haugland et al. | Dec 2005 | B2 |
| 6984459 | Noguchi et al. | Jan 2006 | B1 |
| 7122227 | Vaughn-Spickers et al. | Oct 2006 | B2 |
| 7144950 | Bazan et al. | Dec 2006 | B2 |
| 7214489 | Bazan et al. | May 2007 | B2 |
| 7270956 | Bazan et al. | Sep 2007 | B2 |
| 7384974 | Taguchi et al. | Jun 2008 | B2 |
| 7446202 | Dallwig et al. | Nov 2008 | B2 |
| 7462683 | Yamamoto et al. | Dec 2008 | B2 |
| 7563907 | Czerney et al. | Jul 2009 | B2 |
| 7629448 | Bazan et al. | Dec 2009 | B2 |
| 7666392 | Kolb et al. | Feb 2010 | B2 |
| 7671214 | Leung et al. | Mar 2010 | B2 |
| 7687282 | Tsien et al. | Mar 2010 | B2 |
| 7723455 | Becker et al. | May 2010 | B2 |
| 7767785 | Falcou et al. | Aug 2010 | B2 |
| 7855275 | Eigenbrot et al. | Dec 2010 | B2 |
| 7914984 | Bazan et al. | Mar 2011 | B2 |
| 7947382 | Büsing et al. | May 2011 | B2 |
| 8101416 | Bazan et al. | Jan 2012 | B2 |
| 8110673 | Bazan et al. | Feb 2012 | B2 |
| 8129037 | Stössel et al. | Mar 2012 | B2 |
| 8158444 | Gaylord et al. | Apr 2012 | B2 |
| 8227187 | Bazan et al. | Jul 2012 | B2 |
| 8309300 | Junutula et al. | Nov 2012 | B2 |
| 8343637 | Parham et al. | Jan 2013 | B2 |
| 8354239 | Gaylord et al. | Jan 2013 | B2 |
| 8362193 | Gaylord et al. | Jan 2013 | B2 |
| 8431416 | Diwu et al. | Apr 2013 | B2 |
| 8455613 | Gaylord et al. | Jun 2013 | B2 |
| 8575303 | Gaylord et al. | Nov 2013 | B2 |
| 8617814 | Bazan et al. | Dec 2013 | B2 |
| 8623324 | Dubrovsky et al. | Jan 2014 | B2 |
| 8623332 | Nielsen et al. | Jan 2014 | B2 |
| 8679644 | Parham et al. | Mar 2014 | B2 |
| 8802450 | Gaylord et al. | Aug 2014 | B2 |
| 8841265 | Chan et al. | Sep 2014 | B2 |
| 8969509 | Liu et al. | Mar 2015 | B2 |
| 8993335 | Bazan et al. | Mar 2015 | B2 |
| 9000130 | Bhakta et al. | Apr 2015 | B2 |
| 9012643 | Diwu et al. | Apr 2015 | B2 |
| 9056871 | Ikeda et al. | Jun 2015 | B2 |
| 9073942 | Ramdas et al. | Jul 2015 | B2 |
| 9085799 | Bazan et al. | Jul 2015 | B2 |
| 9139869 | Gaylord et al. | Sep 2015 | B2 |
| 9159465 | Bazan et al. | Oct 2015 | B2 |
| 9240553 | Kosuge et al. | Jan 2016 | B2 |
| 9371559 | Bazan et al. | Jun 2016 | B2 |
| 9383353 | Gaylord et al. | Jul 2016 | B2 |
| 9547008 | Gaylord et al. | Jan 2017 | B2 |
| 9719998 | Liang | Aug 2017 | B2 |
| 9758625 | Bartholomew | Sep 2017 | B2 |
| 9799832 | Takizawa et al. | Oct 2017 | B2 |
| 9896538 | Diwu et al. | Feb 2018 | B2 |
| 9933341 | Li et al. | Apr 2018 | B2 |
| RE46817 | Bazan et al. | May 2018 | E |
| 9971998 | Nuzzi | May 2018 | B2 |
| 9977014 | Lukman et al. | May 2018 | B2 |
| 10001473 | Bazan et al. | Jun 2018 | B2 |
| 10001475 | Bazan et al. | Jun 2018 | B2 |
| 10008671 | Takizawa et al. | Jun 2018 | B2 |
| 10062851 | Kariya et al. | Aug 2018 | B2 |
| 10074813 | Yamamoto et al. | Sep 2018 | B2 |
| 10094838 | Gaylord et al. | Oct 2018 | B2 |
| 10107818 | Gaylord et al. | Oct 2018 | B2 |
| 10228375 | Liang et al. | Mar 2019 | B2 |
| 10240000 | Avakian et al. | Mar 2019 | B2 |
| 10240004 | Bartholomew et al. | Mar 2019 | B2 |
| 10288620 | Gaylord et al. | May 2019 | B2 |
| 10302648 | Gaylord et al. | May 2019 | B2 |
| 10355215 | Nakayama et al. | Jul 2019 | B2 |
| 10365271 | Bazan et al. | Jul 2019 | B2 |
| 10365285 | Gaylord et al. | Jul 2019 | B2 |
| 10458989 | Gaylord et al. | Oct 2019 | B2 |
| 10472521 | Radford et al. | Nov 2019 | B2 |
| 10481161 | Gaylord et al. | Nov 2019 | B2 |
| 10510965 | Matsushita | Dec 2019 | B2 |
| 10533092 | Bartholomew et al. | Jan 2020 | B2 |
| 10545137 | Sharkey et al. | Jan 2020 | B2 |
| RE47874 | Bazan et al. | Feb 2020 | E |
| 10604657 | Bartholomew et al. | Mar 2020 | B2 |
| 10605813 | Liang et al. | Mar 2020 | B2 |
| 10641775 | Gaylord et al. | May 2020 | B2 |
| 10662218 | Mazitschek et al. | May 2020 | B2 |
| 10700286 | Shin et al. | Jun 2020 | B2 |
| 10844228 | Bartholomew et al. | Nov 2020 | B2 |
| 10870668 | Ji et al. | Dec 2020 | B2 |
| 10902969 | Yamamoto et al. | Jan 2021 | B2 |
| 10920082 | Liang et al. | Feb 2021 | B2 |
| 10948485 | Bazan et al. | Mar 2021 | B2 |
| 10955417 | Gaylord et al. | Mar 2021 | B2 |
| 10962546 | Gaylord et al. | Mar 2021 | B2 |
| 11034840 | Bartholomew et al. | Jun 2021 | B2 |
| 11099190 | Martin et al. | Aug 2021 | B2 |
| 11119107 | Liang et al. | Sep 2021 | B2 |
| RE48811 | Bazan et al. | Nov 2021 | E |
| 11208527 | Easwaran et al. | Dec 2021 | B2 |
| 11209438 | Gaylord et al. | Dec 2021 | B2 |
| 11215612 | Bazan et al. | Jan 2022 | B2 |
| 11220628 | Diwu et al. | Jan 2022 | B2 |
| 11333666 | Gaylord et al. | May 2022 | B2 |
| 11485825 | Bartholomew et al. | Nov 2022 | B2 |
| 11492493 | Liang et al. | Nov 2022 | B2 |
| 11499053 | Bartholomew et al. | Nov 2022 | B2 |
| 11584825 | Easwaran et al. | Feb 2023 | B2 |
| 11639937 | Gaylord et al. | May 2023 | B2 |
| 11643556 | Bartholomew et al. | May 2023 | B2 |
| 11668716 | Liang et al. | Jun 2023 | B2 |
| 11719691 | Bazan et al. | Aug 2023 | B2 |
| 11834551 | Easwaran et al. | Dec 2023 | B2 |
| 12018117 | Easwaran et al. | Jun 2024 | B2 |
| 20040082602 | Hagen et al. | Apr 2004 | A1 |
| 20040101909 | Lemieux et al. | May 2004 | A1 |
| 20050059168 | Bazan et al. | Mar 2005 | A1 |
| 20050203289 | Schwartz et al. | Sep 2005 | A1 |
| 20060160109 | MacDonald et al. | Jul 2006 | A1 |
| 20060183140 | Bazan et al. | Aug 2006 | A1 |
| 20070060736 | Becker et al. | Mar 2007 | A1 |
| 20080293164 | Gaylord et al. | Nov 2008 | A1 |
| 20090253118 | Yang et al. | Oct 2009 | A1 |
| 20100150942 | Cantor | Jun 2010 | A1 |
| 20100227974 | Schulte et al. | Sep 2010 | A1 |
| 20110054188 | Koori et al. | Mar 2011 | A1 |
| 20110095280 | Meyer et al. | Apr 2011 | A1 |
| 20110256549 | Gaylord et al. | Oct 2011 | A1 |
| 20110256550 | Gaylord et al. | Oct 2011 | A1 |
| 20120070382 | Liu et al. | Mar 2012 | A1 |
| 20120252986 | Liu et al. | Oct 2012 | A1 |
| 20130011388 | Nur et al. | Jan 2013 | A1 |
| 20130027636 | Marrocco, III et al. | Jan 2013 | A1 |
| 20130108619 | Melamed | May 2013 | A1 |
| 20130177574 | Ravindranath et al. | Jul 2013 | A1 |
| 20130281644 | Kiessling et al. | Oct 2013 | A1 |
| 20140357898 | Kawano et al. | Dec 2014 | A1 |
| 20150144200 | Iketaki et al. | May 2015 | A1 |
| 20160264737 | Bartholomew et al. | Sep 2016 | A1 |
| 20160266131 | Liang et al. | Sep 2016 | A1 |
| 20170115298 | Gaylord et al. | Apr 2017 | A1 |
| 20170117472 | Hongo | Apr 2017 | A1 |
| 20170125694 | Shigenoi et al. | May 2017 | A1 |
| 20170170399 | Masui et al. | Jun 2017 | A1 |
| 20180203015 | Song et al. | Jul 2018 | A1 |
| 20180224460 | Inokuma et al. | Aug 2018 | A1 |
| 20180364245 | Martin et al. | Dec 2018 | A1 |
| 20190144601 | Easswaran et al. | May 2019 | A1 |
| 20190194467 | Liang et al. | Jun 2019 | A1 |
| 20190203052 | Xu et al. | Jul 2019 | A1 |
| 20200048469 | Bartholomew et al. | Feb 2020 | A1 |
| 20200147615 | Huang | May 2020 | A1 |
| 20200181412 | Bartholomew et al. | Jun 2020 | A1 |
| 20200190253 | Easswaran et al. | Jun 2020 | A1 |
| 20200239766 | Xu et al. | Jul 2020 | A1 |
| 20200263084 | Diwu et al. | Aug 2020 | A1 |
| 20210047476 | Bartholomew et al. | Feb 2021 | A1 |
| 20210108083 | Liang et al. | Apr 2021 | A1 |
| 20210373029 | Liang et al. | Dec 2021 | A1 |
| 20220082568 | Gaylord et al. | Mar 2022 | A1 |
| 20220236278 | Gaylord et al. | Jul 2022 | A1 |
| 20220260464 | Diwu et al. | Aug 2022 | A1 |
| 20220260578 | Gaylord et al. | Aug 2022 | A1 |
| 20220276254 | Gaylord et al. | Sep 2022 | A1 |
| 20220276255 | Gaylord et al. | Sep 2022 | A1 |
| 20220283169 | Gaylord et al. | Sep 2022 | A1 |
| 20220340813 | Liang et al. | Oct 2022 | A1 |
| 20220348770 | Bartholomew et al. | Nov 2022 | A1 |
| 20230116275 | Bartholomew et al. | Apr 2023 | A1 |
| 20230192943 | Easwaran et al. | Jun 2023 | A1 |
| 20230243837 | Gaylord et al. | Aug 2023 | A1 |
| 20230251264 | Gaylord et al. | Aug 2023 | A1 |
| 20230288428 | Liang et al. | Sep 2023 | A1 |
| 20230399565 | Tomasulo et al. | Dec 2023 | A1 |
| 20240270971 | Easwaran et al. | Aug 2024 | A1 |
| 20240400893 | Easwaran et al. | Dec 2024 | A1 |
| Number | Date | Country |
|---|---|---|
| 2017250778 | Nov 2018 | AU |
| 112018071026 | Feb 2019 | BR |
| 102019025989 | Jun 2020 | BR |
| 2 365 814 | Jun 2003 | CA |
| 3020926 | Oct 2017 | CA |
| 1594314 | Mar 2005 | CN |
| 101983202 | Mar 2011 | CN |
| 102770465 | Nov 2012 | CN |
| 102267948 | Sep 2013 | CN |
| 102146077 | Oct 2014 | CN |
| 104557723 | Apr 2015 | CN |
| 107973795 | May 2018 | CN |
| 108129496 | Jun 2018 | CN |
| 105585589 | Oct 2018 | CN |
| 109415623 | Mar 2019 | CN |
| 106008138 | Apr 2019 | CN |
| 111320744 | Jun 2020 | CN |
| 1717258 | Nov 2006 | EP |
| 1 074 600 | Jun 2009 | EP |
| 2 289 563 | Mar 2011 | EP |
| 2 714 675 | Feb 2019 | EP |
| 3443049 | Feb 2019 | EP |
| 3 319 138 | Jul 2019 | EP |
| 3 636 635 | Apr 2020 | EP |
| 3670609 | Jun 2020 | EP |
| 3443049 | Apr 2021 | EP |
| 2000-63690 | Feb 2000 | JP |
| 2005-139126 | Jun 2005 | JP |
| 2008519140 | Jun 2008 | JP |
| 2008-290963 | Dec 2008 | JP |
| 2010501030 | Jan 2010 | JP |
| 2010503685 | Feb 2010 | JP |
| 2010-143895 | Jul 2010 | JP |
| 4605412 | Jan 2011 | JP |
| 2011500916 | Jan 2011 | JP |
| 2011-256144 | Dec 2011 | JP |
| 5388030 | Jan 2014 | JP |
| 5438363 | Mar 2014 | JP |
| 5478189 | Apr 2014 | JP |
| 2015-192119 | Nov 2015 | JP |
| 6110802 | Apr 2017 | JP |
| 6152357 | Jun 2017 | JP |
| 6239457 | Nov 2017 | JP |
| 6247560 | Dec 2017 | JP |
| 6247583 | Dec 2017 | JP |
| 2013-517374 | May 2018 | JP |
| 6318452 | May 2018 | JP |
| 2019-6739 | Jan 2019 | JP |
| 2019-512573 | May 2019 | JP |
| 2019519623 | Jul 2019 | JP |
| 2020109162 | Jul 2020 | JP |
| 6882331 | May 2021 | JP |
| 2021102779 | Jul 2021 | JP |
| 2021165407 | Oct 2021 | JP |
| 10-1793428 | Oct 2017 | KR |
| 10-1815773 | Jan 2018 | KR |
| 10-2018-0027195 | Mar 2018 | KR |
| 10-1923936 | Nov 2018 | KR |
| 20180132750 | Dec 2018 | KR |
| 10-1983991 | May 2019 | KR |
| 10-1996648 | Jun 2019 | KR |
| 10-2216472 | Feb 2021 | KR |
| 9013540 | Nov 1990 | WO |
| 9200748 | Jan 1992 | WO |
| 9216555 | Oct 1992 | WO |
| 9404193 | Mar 1994 | WO |
| 9414758 | Jul 1994 | WO |
| 9417039 | Aug 1994 | WO |
| 9418247 | Aug 1994 | WO |
| 9428937 | Dec 1994 | WO |
| 9511924 | May 1995 | WO |
| 9513312 | May 1995 | WO |
| 9600080 | Jan 1996 | WO |
| 9621469 | Jul 1996 | WO |
| 9623794 | Aug 1996 | WO |
| 9703106 | Jan 1997 | WO |
| 9807713 | Feb 1998 | WO |
| 9841562 | Sep 1998 | WO |
| 9848837 | Nov 1998 | WO |
| 9851757 | Nov 1998 | WO |
| 9926299 | May 1999 | WO |
| 9930727 | Jun 1999 | WO |
| 9932134 | Jul 1999 | WO |
| 9933483 | Jul 1999 | WO |
| 9945964 | Sep 1999 | WO |
| 9953951 | Oct 1999 | WO |
| 0126692 | Apr 2001 | WO |
| 03096016 | Nov 2003 | WO |
| 2005014689 | Feb 2005 | WO |
| 2005100437 | Oct 2005 | WO |
| 2006040530 | Apr 2006 | WO |
| 2006080406 | Aug 2006 | WO |
| 2008100344 | Aug 2008 | WO |
| 2009051560 | Apr 2009 | WO |
| 2010006852 | Jan 2010 | WO |
| 2010151807 | Dec 2010 | WO |
| 2011091086 | Jul 2011 | WO |
| 2011119272 | Sep 2011 | WO |
| 2011126225 | Oct 2011 | WO |
| 2014042322 | Mar 2014 | WO |
| 2014124198 | Aug 2014 | WO |
| 2016019929 | Feb 2016 | WO |
| 2016073052 | May 2016 | WO |
| 2016144653 | Sep 2016 | WO |
| 2017180998 | Oct 2017 | WO |
| 2017180998 | Dec 2017 | WO |
| 2018111774 | Jun 2018 | WO |
| 2019023463 | Jan 2019 | WO |
| 2021101145 | May 2021 | WO |
| 2021252368 | Dec 2021 | WO |
| 2022013198 | Jan 2022 | WO |
| 2022104147 | May 2022 | WO |
| 2022235705 | Nov 2022 | WO |
| Entry |
|---|
| “U.S. Appl. No. 16/092,180, Final Office Action mailed Apr. 30, 2021”, 7 pgs. |
| “U.S. Appl. No. 16/092,180, Non Final Office Action mailed Jan. 21, 2021”, 8 pgs. |
| “U.S. Appl. No. 16/092,180, Notice of Allowance mailed Jul. 21, 2021”, 7 pgs. |
| “U.S. Appl. No. 16/092,180, Notice of Allowance mailed Oct. 18, 2021”, 5 pgs. |
| “U.S. Appl. No. 16/092,180, Response filed Apr. 21, 2021 to Non Final Office Action mailed Jan. 21, 2021”, 18 pgs. |
| “U.S. Appl. No. 16/092,180, Response filed Jun. 30, 2021 to Final Office Action mailed Apr. 30, 2021”, 19 pgs. |
| “U.S. Appl. No. 16/092,180, Response filed Nov. 10, 2020 to Restriction Requirement mailed Sep. 10, 2020”, 17 pgs. |
| “U.S. Appl. No. 16/092,180, Restriction Requirement mailed Sep. 10, 2020”, 7 pgs. |
| “Australian Application Serial No. 2017250778, First Examination Report mailed Oct. 9, 2020”, 4 pgs. |
| “Australian Application Serial No. 2017250778, Response filed Aug. 4, 2021 to First Examination Report mailed Oct. 9, 2021”. 35 pgs. |
| “Australian Application Serial No. 2019280076, First Examination Report mailed Jun. 18, 2021”, 3 pgs. |
| “Becton Dickinson Filed a Case Against Beckman Coulter Over Alleged Patent Infringement”, MaxVal, [Online] Retrieved from the Internet: <URL: https://www.maxval.com/blog/becton-dickinson-filed-a-case-against-beckman-coulter-over-alleged-patent-infringement/>, [Retrieved on Sep. 29, 2021], (Jul. 1, 2021), 6 pgs. |
| “Brazilian Application Serial No. 1120180710261, Office Action mailed Jun. 1, 2021”, w/ English Machine Translation, 10 pgs. |
| “Brazilian Application Serial No. 1120180710261, Office Action mailed Aug. 13, 2021”, w/ English Claims, 80 pgs. |
| “Brazilian Application Serial No. 1120180710261, Voluntary Amendment filed Apr. 8, 2020”, w/English claims, 36 pgs. |
| “Chinese Application Serial No. 201780031306.5, Office Action mailed May 8, 2021”, w/ English Translation, 32 pgs. |
| “Chinese Application Serial No. 201780031306.5, Response filed Aug. 17, 2021 to Office Action mailed May 8, 2021”, w/o English Claims, 34 pgs. |
| “European Application Serial No. 17737077.2, Intention to Grant a European Patent mailed Mar. 18, 2021”, w/ Allowed Claims, 12 pgs. |
| “European Application Serial No. 17737077.2, Response filed May 23, 2019 to Communication pursuant to Rules 161(1) and 162 EPC mailed Nov. 22, 2018”, 29 pgs. |
| “European Application Serial No. 19216268.3, Extended European Search Report mailed May 26, 2020”, 7 pgs. |
| “European Application Serial No. 19216268.3, Response filed Dec. 18, 2020 to Extended European Search Report mailed May 26, 2020”, 15 pgs. |
| “European Application Serial No. 21156248.3, Extended European Search Report mailed Oct. 8, 2021”, 5 pgs. |
| “European Application Serial No. 21156248.3, Response to Rule 58 filed Apr. 28, 2021”, 12 pgs. |
| “Indian Application Serial No. 201847039964, First Examination Report dated Jul. 7, 2020”, w/English Translation, 6 pgs. |
| “Indian Application Serial No. 201847039964, Hearing Notice mailed Jan. 1, 2021”, 2 pgs. |
| “Indian Application Serial No. 201847039964, Response filed Dec. 24, 2020 to First Examination Report, dated Jul. 7, 2020”, 44 pgs. |
| “International Application Serial No. PCT/US2017/027611, International Preliminary Report on Patentability mailed Oct. 25, 2018”, 10 pgs. |
| “International Application Serial No. PCT/US2017/027611, International Search Report”, mailed Dec. 7, 2017, 5 pgs. |
| “International Application Serial No. PCT/US2017/027611, Invitation to Pay Add'l Fees and Partial Search Report”, mailed Oct. 11, 2017, 9 pgs. |
| International Application Serial No. PCT/US2017/027611, Written Opinion mailed Dec. 7, 2017, 8 pgs. |
| “Japanese Application Serial No. 2018-554032, Decision to Grant a Patent mailed Apr. 26, 2021”, w/ English Translation and Allowed Claims, 22 pgs. |
| “Japanese Application Serial No. 2018-554032, Notification of Reasons for Rejection mailed Jan. 15, 2021”, w/ English Translation, 9 pgs. |
| “Japanese Application Serial No. 2018-554032, Response filed Apr. 2, 2021 to Office Action mailed Jan. 15, 2021”, w/ English Translation, 56 pgs. |
| “Japanese Application Serial No. 2021-63576, Voluntary Amendment filed Jul. 14, 2021”, w/ English claims, 24 pgs. |
| “Korean Application Serial No. 10-2018-7031258, Notice of Allowance mailed Aug. 23, 2021”, w/ English Translation, 4 pgs. |
| “Korean Application Serial No. 10-2018-7031258, Notice of Preliminary Rejection mailed Mar. 11, 2021”, w/ English Translation, 17 pgs. |
| “Korean Application Serial No. 10-2018-7031258, Response filed May 11, 2021 to Notice of Preliminary Rejection mailed Mar. 11, 2021”, w/ English claims, 64 pgs. |
| An, Lingling, et al., “A Fluorescence Ratiometric Protein Assay Using Light-Harvesting Conjugated Polymers”, Macromol. Rapid Commun. 2006, 27, (2006), 993-997. |
| An, Lingling, et al., “Cationic conjugated polymers for homogeneous and sensitive fluorescence detection of hyaluronidase”, Sci China Ser B-Chem, 52(6), (Jun. 2009), 827-832. |
| Bernius, Mark T., et al., “Progress with Light-Emitting Polymers”, Adv. Mater. 2000, 12(23), (Dec. 1, 2000), 1737-1750. |
| Burrows, Hugh D., et al., “Aqueous Solution Behavior of Anionic Fluorene-co-thiophene-Based Conjugated Polyelectrolytes”, Applied Materials and Interfaces, 1(4), (2009), 864-874. |
| Chen, Yi, et al., “Water-Soluble Anionic Conjugated Polymers for Metal lon Sensing: Effect of Interchain Aggregation”, Journal of Polymer Science, Part A: Polymer Chemistry, 47(19), (2009), 5057-5067. |
| Feng, Fude, et al., “Water-Soluble Conjugated Polymers for Fluorescent-Enzyme Assays”, Macromol. Rapid Commun. 2010, 31, (2010), 1405-1421. |
| Gaylord, Brent S., et al., “DNA detection using water-soluble conjugated polymers and peptide nucleic acid probes”, PNAS, 99(17), (2002), 10954-10957. |
| Gaylord, Brent, et al., “DNA Hybridization Detection with Water-Soluble Conjugated Polymers and Chromophore-Labeled Single-Stranded DNA”, J. Am. Chem. Soc., 125(4), (2003), 896-900. |
| Gaylord, Brent S., et al., “SNP detection using peptide nucleic acid probes and conjugated polymers: Applications in neurodegenerative disease identification”, PNAS, 102(1), (Jan. 4, 2005), 34-39. |
| Hou, Qiong, et al., “Novel red-emitting fluorene-based copolymers”, J. Mater. Chem., 2002, 12, (2002), 2887-2892. |
| Inbasekaran, Michael, et al., “Fluorene homopolymers and copolymers”, Synthetic Metals 111-112, (2000), 397-401. |
| Lee, Kangwon, et al., “Sensitive and Selective Label-Free DNA Detection by Conjugated Polymer-Based Microarrays and Intercalating Dye”, Chem. Mater. 2008, 20(9), (2008), 2848-2850. |
| Li, Kai, et al., “Generic Strategy of Preparing Fluorescent Conjugated- Polymer-Loaded Poly(DL-lactide-co-Glycolide) Nanoparticles for Targeted Cell Imaging”, Adv. Funct. Mater. 2009, 19, (2009), 3535-3542. |
| Office Action dated Jan. 8, 2024 in corresponding Chinese Application No. 202110960650.0 with English Translation, 14 pages. |
| Li, Kai, et al., “Water-soluble conjugated polymers as the platform for protein sensors”, Polym. Chem., 2010, 1., (2010), 252-259. |
| Liu, Bin, et al., “Synthesis of a novel cationic water-soluble efficient blue photoluminescent conjugated polymer”, Chem. Commun., 2000, (2000), 551-552. |
| Liu, Bin, et al., “Synthesis of cationic conjugated polymers for use in label-free DNA microarrays”, Nature Protocols, 1 (4), (2006), 1698-1702. |
| Pei, Qibing, et al., “Efficient Photoluminescence and Electroluminescence from a Soluble Polyfluorene”, J. Am. Chem. Soc. 1996, 118, (1996), 7416-7417. |
| Pu, Fang, et al., “Universal Platform for Sensitive and Label-Free Nuclease Assay Based on Conjugated Polymer and DNA/Intercalating Dye Complex”, Langmuir 2010, 26(6), (2010), 4540-4545. |
| Shi, Jianbing, et al., “Synthesis and Characterization of Water-Soluble Conjugated Glycopolymer for Fluorescent Sensing of Concanavalin A”, Chem. Asian J. 2010, 5, (2010), 301-308. |
| Stork, Martin, et al., “Energy Transfer in Mixtures of Water-Soluble Oligomers: Effect of Charge, Aggregation, and Surfactant Complexation”, Adv. Mater. 2002, 14(5), (Mar. 4, 2002), 361-366. |
| Sun, Chengjun, et al., “Application of cationic conjugated polymers in microarrays using label-free DNA targets”, Nature Protocols, 2(9), (2007), 2148-2151. |
| Wang, Shu, et al., “Fluorescein Provides a Resonance Gate for FRET from Conjugated Polymers to DNA Intercalated Dyes”, J. Am. Chem. Soc., 126(17), (2004), 5446-5451. |
| Xue, Cuihua, et al., “Facile, Versatile Prepolymerization and Postpolyrnerization Functionalization Approaches for Well-Defined Fluorescent Conjugated Fluorene-Based Glycopolymers”, Macromolecules 2006, 39, (2006), 5747-5752. |
| Xue, Cuihua, et al., “Highly Water-Soluble, Fluorescent, Conjugated Fluorene-Based Glycopolymers with Poly (ethylene glycol)-Tethered Spacers for Sensitive Detection of Escherichia coli”, Chem. Eur. J. 2009, 15, (2009), 2289-2295. |
| Yamamoto et al. “IT-Conjugated Polymers Consisting of 9,10-Dihydrophenanthrene Units” Macromol. Chem. Phys. 2011, vol. 212, pp. 2406-2416. |
| Yamamoto, T, et al., “Synthesis of soluble poly(9, 10-dihydrophenanthrene-2,7-diyl)s.A new class of luminescent poly (p-phenylene)s with ethylene type bridges”, Polymer, Elsevier Science Publishers B.V, GB, vol. 45, No. 24, (Nov. 1, 2004), 8085-8089. |
| European Search Report for application EP22215653-1108, dated Mar. 27, 2023, 7 pages. |
| Office Action mailed Mar. 2, 2023 in Japanese patent application No. 2021-116347, and English translation thereof, 8 pages total. |
| Bao et al., “Investigation of Conjugated Polymers for Metal Ion Sensing,” Acta Chimica Sinica, vol. 71, pp. 1379-1384 (2013). |
| Chakraborty et al., Fluorescence excitation spectrum of jet-cooled 9, 10-dihydrophenanthrene, Chemical Physics Letters, vol. 177, No. 2, pp. 223-228 (1991). |
| Office Action dated Jan. 26, 2024 in corresponding Chinese Application No. 202110962097.4 with English Translation, 14 pages. |
| Chinta et al., “Coumarin (5,6-Benzo-2-pyrone) Trapping of an HDDA-Benzyne,” Organic Letters, vol. 23, pp. 2189-2193 (2021). |
| Fu et al., “Regioselective Synthesis of Polycyclic and Heptagon-embedded Aromatic Compounds through a Versatile p-Extension of Aryl Halides,” Angewandte Chemie International Edition, DOI: 10.1002/anie.201703551, vol. 56, pp. 7166-7170 (May 2017). |
| Kiel et al., “Zirconacyclopentadiene-Annulated Polycyclic Aromatic Hydrocarbons,” Angewandte Chemie International Edition, Author Manuscript, https://doi.org/10.1002/anie.201700818, vol. 56, No. 17, pp. 4839-4844 (Apr. 18, 2017). |
| Martinez et al., “Dibenzoanthradiquinone Building Blocks for the Synthesis of Nitrogenated Polycyclic Aromatic Hydrocarbons,” Organic Letters, vol. 22, pp. 4737-4741 (2020). |
| Toume et al., “Cytotoxic dimeric sesquiterpenoids from Curcuma parviflora: isolation of three new parviflorenes and absolute stereochemistry of parviflorenes A, B, D, F, and G,” Tetrahedron, vol. 61, pp. 6700-6706 (2005). |
| Extended European Search Report for Application No. 24167704.6 mailed Jun. 28, 2024. |
| Adachi et al., “Syntheses of 2- and 3-Isopropyl-1-methylnapthalenes from Cyclic β- and γ-Keo Esters,” The Chemical Society of Japan, vol. 1, pp. 62-68 (1980). |
| Baig et al., “Conjugated copolymers bearing 2,7-dithienylphenanthrene-9, 10-dialkoxy units: highly soluble and stable deep-blue emissive materials,” New J. Chem., vol. 40, pp. 9557-9564 (2020). |
| Bandi et al., “Targeted multicolor in vivo imaging over 1,000 nm enabled by nonamethine cyanines,” Nature Methods, vol. 19, pp. 253-258 (Mar. 2022). |
| Bruchez, Jr. et al., “Semiconductor Nanocrystals as Fluorescent Biological Labels,” Science, vol. 281, pp. 2013-2016 (1998). |
| Cyanine 5, SE Data Sheet, bio-techne.com, 2 pages (Jul. 21, 2022). |
| Davis et al., “Effect of Buffer Conditions and Organic Cosolvents on the Rate of Strain-Promoted Azide—Alkyne Cycloaddition,” J. Org. Chem. vol. 81, No. 15, pp. 6816-6819, with Supporting Information, pp. S1-S41 (2016). |
| Delagrave et al., “Red-Shifted Excitation Mutants of the Green Fluorescent Protein,” Bio/Technology, vol. 13, pp. 151-154 (Feb. 1995). |
| E. Schroder and K. Lubke, “The Peptides”; vol. 1, Academic Press, New York, 1965, pp. 76-136. |
| Fissi et al., “Photoresponsive Polymers. Photomodulation of the Macromolecular Structure in Poly(L-lysine) Containing Spiropyran Units,” Macromolecules, vol. 28, pp. 302-309 (1995). |
| FNIR-Tag-NHS Data Sheet, bio-techne.com, 2 pages (Oct. 31, 2022). |
| Geierstanger et al., “Complexes of the Minor Groove of DNA,” Annu. Rev. Biophys. Biomol. Struct., vol. 24, pp. 463-493 (1995). |
| Glumoff, T. and Goldman, A. Nucleic Acids in Chemistry and Biology, 2.sup.nd ed., Blackburn, G. M. and Gait, M. J., Eds., Oxford University Press: Oxford, pp. 375-441 (1996). |
| Green and Wuts, Greene's Protective Groups in Organic Synthesis, 4th Ed. 2007, Wiley-Interscience, New York, Protection for the Amino Group, cover-xxviii, and Ch. 7, pp. 696-926. |
| Heim et al., “Wavelength mutations and posttranslational autoxidation of green fluorescent protein,” Proc. Natl. Acad. Sci. USA, vol. 91, pp. 12501-12504 (Dec. 1994). |
| Heim et al., “Improved green fluorescence,” Nature, vol. 373, pp. 663-664 (Feb. 1995). |
| Indocyanine green Data Sheet, bio-techne.com, 2 pages (Dec. 9, 2022). |
| IUPAC Definition, “What are Polymers?,” 3 pages (Downloaded 2024). |
| IUPAC Glossary of Basic Terms in Polymer Science, Pure & Appl. Chem., vol. 68, No. 12, pp. 2287-2311 (1996). |
| IUPAC Glossary of Terms used in Physical Organic Chemistry, Pure & Appl. Chem., vol. 66, No. 5, pp. 1077-1184 (1994). |
| K. D. Kopple, “Peptides and Amino Acids”, W. A. Benjamin, Inc., New York, 1966, pp. 50-51. |
| Kim et al., “Biomedical applications of copper-free click chemistry: in vitro, in vivo, and ex vivo,” Chem. Sci., vol. 10, No. 34, pp. 7835-7851 (2019). |
| Larson, C. J. and Verdine, G. L., Bioorganic Chemistry: Nucleic Acids, Hecht, S. M., Ed., Oxford University Press: New York, Chapter 11, “The Chemistry of Protein-DNA Interactions,” pp. 324-346 (1996). |
| Lu et al., “Phase Behavior of Blends of Poly (ethylene glycol) and Partially Neutralized Poly (acrylic acid),” Macromolecules, vol. 28, pp. 3022-3029 (1995). |
| m-PEG8-Tos Data Sheet, BroadPharm, 5 pages (Copyright 2022). |
| Michie et al., “Cyanine Conformational Restraint in the Far-Red Range,” J. Am. Chem. Soc., vol. 139, pp. 12406-12409 (2017). |
| Mottaghipisheh et al., “Sephadex® LH-20, Isolation, and Purification of Flavonoids from Plant Species: A Comprehensive Review,” Molecules, 25, 4146; doi: 10.3390/molecules25184146, pp. 1-19 (2020). |
| Neunhoeffer et al., “Synthesis and sensitizing behavior of pyrenothiazole carbocyanines and pyrenothiazine carbocyanines, I PYRENO[4′.3′:4.5]Thiazole Carbocyanine,” Justus Liebigs Annalen der Chemie, vol. 647, No. 1, pp. 101-107 (1961) (In German with English Translation). |
| Sephadex LH-20 Gel Filtration Package Insert, Cytiva, 56119097 AE V:4, 12 pages (Nov. 2020). |
| Sephadex LH-20 Product Specification, Sigma-Aldrich, 1 page (Downloaded-2024). |
| Strekowski et al., “Substitution Reactions of a Nucleofugal Group in Heptamethine Cyanine Dyes. Synthesis of an Isothiocyanato Derivative for Labeling of Proteins with a Near-Infrared Chromophore,” J. Org. Chem., vol. 57, No. 17, pp. 4578-4580 (1992). |
| Su et al., “The development of a highly photostable and chemically stable zwitterionic near-infrared dye for imaging applications,” Chem. Commun., vol. 51, pp. 3989-3992 (2015). |
| Tomasulo et al., “Synthesis and Properties of Benzophenone-Spiropyran and Naphthalene-Spiropyran Conjugates,” J. Org. Chem., vol. 72, pp. 595-605 (2007). |
| Yan et al., “Palladium-catalyzed cross-coupling reaction of sulfoxonium ylides and benzyl bromides by carbene migratory insertion,” Chem. Commun., vol. 56, pp. 14287-14290 (2020). |
| Zalipsky et al., “Introduction to Chemistry and Biological Applications of Poly(ethylene glycol),” Chapter 1, ACS Symposium Series, American Chemical Society, Washington, DC, pp. 1-13 (1997). |
| Zhiryakov et al., Polymethine Dyes Derived from Heterocyclic Bases Containing Condensed Thiophene Rings. VII: Thionaphthenopyrid-3-Yl and Thienothienopyrid-6-Yl Derivatives, Chemistry of Heterocyclic Compunds, No. 3, pp. 491-497 (1969) (In English and Russian). |
| Zhu et al., “Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy,” Chem. Rev., vol. 112, No. 8, pp. 4687-4735 (2012). |
| Acceptor Dye DY-675, 1 page, Dyomics GmbH. |
| Acceptor Dye DY-705, 2 pages, Dyomics GmbH. |
| Barendt et al., “Supramolecular Assemblies for Electronic Materials,” Chem. Eur. J., vol. 26, pp. 3744-3748 (2020). |
| BASF Industrial Formulators Core Range, 21 pages (Feb. 5, 2021). |
| BD Horizon™ Brilliant Stain Buffer, Technical Data Sheet, BD Biosciences, 563794 Rev. 8, 3 pages (Copyright 2017). |
| BD Horizon ™ BUV395 Mouse Anti-Human CD4, Technical Data Sheet, BD Biosciences, 2 pages (Copyright 2011). |
| BD Horizon™ BV605 Mouse Anti-Human CD56, Technical Data Sheet, 562779 Rev. 2, BD Biosciences, 2 pages (Copyright 2014). |
| Bisht et al., “Fused Fluorenylindolenine-Donor-Based Unsymmetrical Squaraine Dyes for Dye-Sensitized Solar Cells,” ACS Applied Materials & Interfaces, vol. 10, pp. 26335-26347 (2018). |
| Eustaquio et al., “Development of new 2-piperidinium-4-styrylcoumarin derivatives with large Stokes shifts as potential fluorescent labels for biomolecules,” RCS Advances, vol. 12, pp. 8477-8484 (2022). |
| Gauthier et al., “Peptide/protein-polymer conjugates: synthetic strategies and design concepts,” Chem. Commun., pp. 2591-2611 (2008). |
| Gordon et al., “Synthesis of end-labeled multivalent ligands for exploringcell-surface-receptor-ligand interactions,” Chemistry & Biology, vol. 7, pp. 9-16 (2000). |
| Haugland, “Antibody Conjugates for Cell Biology,” Current Protocols in Cell Biology, Supplement 6, pp. 16.5.1-16.5.22 (2000). |
| He et al., “Visible-light-initiated malic acid-promoted cascade coupling/cyclization of aromatic amines and KSCN to 2-aminobenzothiazoles without photocatalyst,” Chinese Chemical Letters, vol. 31, pp. 1895-1898 (2020). |
| Heeger et al., “Making sense of polymer-based biosensors,” PNAS, vol. 96, No. 22, pp. 12219-12221 (Oct. 26, 1999). |
| Heredia et al., “Synthesis of protein-polymer conjugates,” Organic & Biomolecular Chemistry, vol. 5, p. 45-53 (2007). |
| Hermanson, Bioconjugate Techniques, 2nd Edition, Excerpts, 142 pages (2008). |
| Ilina et al., “Squaraine Dyes: Molecular Design for Different Applications and Remaining Challenges,” Bioconjug Chem. Feb. 19, 2020; 31(2): 194-213. doi:10.1021/acs.bioconjchem.9b00482. |
| PCT/US2017/027611, “International Search Report and Writen Opinion,” dated Dec. 7, 2017, 17 pages. |
| Khan et al., “Practical synthesis of an amphiphilic, non-ionic poly(paraphenyleneethynylene) derivative with a remarkable quantum yield in water,” Chem. Commun., pp. 584-586 (2005). |
| Kim et al., “Nonspecific Interactions of a Carboxylate-Substituted PPE with Proteins. A Cautionary Tale for Biosensor Applications,” Langmuir, vol. 21, pp. 7985-7989 (2005). |
| Kolliphor® P 188 Geismar Technical Information, WF-No. DAWF-2019-0839, pp. 1-9 (Mar. 2020). |
| Kreyenschmidt et al., “A New Soluble Poly(p-phenylene) with Tetrahydropyrene Repeating Units,” Macromolecules, vol. 28, pp. 4577-4582 (1995). |
| Kuroda et al., “Synthesis of a nonionic water soluble semiconductive polymer,” Chem. Commun., pp. 26-27 (2003). |
| Lawson-Wood et al., Determination of Relative Fluorescence Quantum Yields usign the FL6500 Fluorescence Spectrometer, Application Note, Fluorescence Spectroscopy, PerkinElmer, Inc., 5 pages (Copyright 2018). |
| Lee, Kangwon, “Functionalized Conjugated Polymers for Signal Amplifying Biosensors and Sensor Arrays,” Submitted to the Graduate School of the University of Michigan for the degree of Doctor of Philosphy, 289 pages (2008). |
| Liu, Bin et al., “Shape-Adaptable Water-Soluble Conjugated Polymers,” J. Am. Chem. Soc., vol. 125, pp. 13306-13307 (2003). |
| Lou et al., “Polymer-Based Elemental Tags for Sensitive Bioassays,” Angew. Chem. Int. Ed., vol. 46, pp. 6111-6114 (2007). |
| McQuade et al., “Conjugated Polymer-Based Chemical Sensors,” Chem. Rev., vol. 100, pp. 2537-2574 (2000). |
| Panchuk-Voloshina et al., “Alexa Dyes, a Series of New Fluorescent Dyes that Yield Exceptionally Bright, Photostable Conjugates,” The Journal of Histochemistry & Cytochemistry, vol. 47(9), pp. 1179-1188 (1999). |
| U.S. Appl. No. 61/296,379, filed Jan. 19, 2010 entitled “Novel Reagents Directed Biomarker Signal Amplification”. |
| U.S. Appl. No. 61/358,406, filed Jun. 24, 2010 entitled “Novel Reagents for Directed Biomarker Signal Amplification”. |
| Qiu et al., “A New Nonfullerene Electron Acceptor with a Ladder Type Backbone for High-Performance Organic Solar Cells,” Advanced Materials, 29, 1604964, 5 pages (2017). |
| Shapiro, Practical Flow Cytometry, Fourth Edition, Excerpts, 170 pages (2003). |
| Sumranjit, “Conjugated Organic Molecules as Models for Potential Sensors,” Submitted to the Graduate School of the University of Massachusetts Amherst for the degree of Doctor of Philosophy, 139 pages (Feb. 2007). |
| The Nobel Prize in Chemistry 2000, 2 pages (2000). |
| Thomas III et al., “Chemical Sensors Based on Amplifying Fluorescent Conjugated Polymers,” Chem. Rev., vol. 107, pp. 1339-1386 (2007). |
| Mra et al., “Fluorescent-labeled antibodies: Balancing functionality and degree of labeling,” Analytical Biochemistry, vol. 402, pp. 146-150 (2010). |
| Wang et al., “Synthesis and application of a novel 9,9-diethyl-1,2-diaryl-1,9-dihydrofluoreno[2,3-d]imidazole for blue organic light emitting diode,” Chin. Chem. Lett. (2019), https://doi.org/10.1016/j.cclet.2019.05.044 (Article in Press). |
| Xue, Cuihua et al., “Synthesis of Highly Water-Soluble Fluorescent Conjugated Glycopoly(p-phenylene)s for Lectin and Escherichia coli,” Biomacromolecules, vol. 7, pp. 2470-2474 (2006). |
| Zalipsky, “Functionalized Poly(ethylene glycol) for Preparation of Biologically Relevant Conjugates,” Bioconjugate Chem., vol. 6, pp. 150-165 (1995). |
| Zhou et al., “Fluorescent Chemosensors Based on Energy Migration in Conjugated Polymers: The Molecular Wire Approach to Increased Sensitivity,” J. Am. Chem. Soc., vol. 117, pp. 12593-12602 (1995). |
| Zhou et al., “Methodology for Enhancing the Sensitivity of Fluorescent Chemosensors: Energy Migration in Conjugated Polymers,” J. Am. Chem. Soc., vol. 117, pp. 7017-7018 (1995). |
| Australian First Examination Report for Application No. 2023203991 mailed Feb. 25, 2025, 11 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20240052092 A1 | Feb 2024 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62323444 | Apr 2016 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16092180 | US | |
| Child | 17395248 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 17700219 | Mar 2022 | US |
| Child | 18483309 | US | |
| Parent | 17395248 | Aug 2021 | US |
| Child | 17700219 | US |
